Capturing Pluripotency and Beyond

Chih-Yu Yeh1, Wei-Han Huang1, Hung-Chi Chen1,2

  • 1Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.

Cells
|December 24, 2021
PubMed

Insights

Embryonic stem cells (ESCs) can achieve expanded pluripotency, mimicking early embryo cells. Understanding these potency states in ESCs and epiblasts clarifies mammalian development.

Area of Science:

  • Developmental Biology
  • Stem Cell Biology
  • Epigenetics

Background:

  • Cell lineage specification begins with pluripotent epiblasts in early embryos.
  • Embryonic stem cells (ESCs) in vitro model the self-renewal and differentiation of epiblasts.
  • Totipotency and expanded pluripotency are key developmental states, with recent insights into their characteristics.

Purpose of the Study:

  • To review the acquisition of epiblast identity during embryogenesis.
  • To compare pluripotent fates and beyond in embryonic stem cells (ESCs) and their in vivo counterparts.
  • To elucidate the molecular mechanisms underlying transitions between different stem cell potency states.

Main Methods:

  • Comparative analysis of mouse and human pluripotent stem cells (PSCs).
  • Review of recent studies on epiblast development and ESC properties.
  • Examination of molecular roadmaps governing potency state transitions.

Main Results:

  • A subset of ESCs exhibits expanded developmental potential, resembling two-cell embryo blastomeres (2CLCs).
  • Reprogramming ESCs generates expanded/extended pluripotent stem cells (EPSCs) with unique properties.
  • Molecular pathways driving potency state changes are increasingly understood.

Conclusions:

  • Understanding potency states in epiblasts and ESCs is crucial for deciphering mammalian development.
  • Comparing potency network components across species offers insights into developmental differences.
  • Recent findings advance the comprehension of stem cell plasticity and developmental potential.

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.3K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.6K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.0K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K